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ABSTRACT

INTRODUCTION

Numerous genomic studies are underway to determine which genes are abnormally regulated by DNA
methylation in disease. However, we have a poor
understanding of how disease-specific methylation
changes affect expression. We thus developed an integrative analysis tool, Methylation-based Gene Expression Classification (ME-Class), to explain specific variation in methylation that associates with
expression change. This model captures the complexity of methylation changes around a gene promoter. Using 17 whole-genome bisulfite sequencing and RNA-seq datasets from different tissues
from the Roadmap Epigenomics Project, ME-Class
significantly outperforms standard methods using
methylation to predict differential gene expression
change. To demonstrate its utility, we used ME-Class
to analyze 32 datasets from different hematopoietic
cell types from the Blueprint Epigenome project.
Expression-associated methylation changes were
predominantly found when comparing cells from distantly related lineages, implying that changes in the
cell’s transcriptional program precede associated
methylation changes. Training ME-Class on normaltumor pairs from The Cancer Genome Atlas indicated
that cancer-specific expression-associated methylation changes differ from tissue-specific changes.
We further show that ME-Class can detect functionally relevant cancer-specific, expression-associated
methylation changes that are reversed upon the removal of methylation. ME-Class is thus a powerful
tool to identify genes that are dysregulated by DNA
methylation in disease.

Establishment of specific patterns of DNA methylation at
CG dinucleotides (CpGs) is necessary for normal development (1,2), and aberrant methylation is frequently observed in cancer (3,4). CpG rich-regions, often called CpG
islands (CGIs), are typically unmethylated and associated
with ∼70% of mammalian gene promoters (5). Hypermethylation of CpG islands overlapping the transcription start
site (TSS) is hypothesized to downregulate tumor suppressor genes, thus promoting tumorigenesis (6,7). Typically,
promoters are labeled as either methylated and silenced or
unmethylated and potentially active based on the methylation levels near the transcription start site (TSS) (8,9). However, studies that rely upon this simple binary characterization (10) to correlate methylation with expression find only
modest negative correlations with expression levels (11–13).
The most common approach to associate DNA methylation and expression change is to first identify differentially
methylated regions (DMRs) and then associate them with
nearby genes. Numerous statistical tools have been developed to identify DMRs (10). Generally, DMRs are found
by segmenting the genome into equally spaced regions and
identifying which regions have statistically significant differences in methylation. DMRs are then associated with genes
or other genomic regulatory elements within a certain distance to gain biological insight into their potential function. While DMR-based methods have been critically important in identifying imprinted loci (14), studies often find
only weak correlations between DMRs near gene promoters and differential gene expression (11,12,15). One drawback of DMR methods is that they rely on a set of arbitrarily defined thresholds for the size and number of CpGs
to include in the DMR. It is often recommended to adjust
these parameters for each individual dataset since the choice
of these parameters has substantial implications in the numbers of DMRs identified and putatively associated genes.
One possible reason DMR methods fail to find a strong
association between differential methylation and expression
is they reduce DNA methylation to a single differential
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MATERIALS AND METHODS
Roadmap Epigenomics Project (REP) WGBS and mRNAseq
Samples from 17 primary tissues with matched whole
genome bisulfite sequencing (WGBS) and RNA-seq were
obtained from the Roadmap Epigenomics Project (REP,
Supplementary Table S1) (22). Fractional methylation (M)
is defined as mCG/CG. Differential methylation (M) is
defined as: M = MS2 − MS1 , where S1 and S2 correspond
to the first and second sample in the differential comparison, respectively. We obtained consolidated methylation
data, which was previously cross-assay standardized and
uniformly processed. All CpG sites were filtered for 4×
coverage or greater and analysis was performed using the
hg19 genome assembly according to analysis standards established in REP. We used uniformly processed proteincoding gene level annotations from Genecode V10 to obtain
standardized FPKM values. Each Genecode V10 annotation was converted to RefSeq annotations using the mygene
python package (23). To create a standardized gene set with
high quality methylation data, we excluded genes with ambiguous or incomplete TSS annotations, genes shorter than
5 kb, genes with <40 CpGs assayed within ±5 kb of the
TSS, genes where all CpGs within ±5 kb of the TSS had
<0.2 methylation change, and alternative promoters. These
filters were used to exclude non-coding and pseudogenes,
genes shorter than the interpolation boundary, genes with
low numbers of CpGs to reduce bias caused by individual

CpGs, and genes with no methylation changes near their
promoter, respectively. We only included RefSeq genes with
cdsStartStat (n = 47 637 genes) and cdsEndStat (n = 47 621
genes) with ‘cmpl’ according to the UCSC Table Browser.
To eliminate redundant annotations, for any RefSeq genes
with multiple RefSeq IDs corresponding to the same TSS
location, we only used a single RefSeq ID with the lowest
accession number. In analyses with the ROI classifier (see
below), all genes with less than four exons were removed
from analysis. Differentially expressed genes were defined as
genes with ≥2-fold difference between samples after an applied floor of five FPKM to provide a conservative estimate
of expression change. These filtering criteria have minimal
effect on the fraction of CpG Island (CGI) -associated promoters, which went from 65.9% of genes before filtering to
67.3% after. CpG Islands were defined based on the CGI
track from the UCSC Genome Browser (24). A full summary of filtered gene counts is in Supplementary Table S2.
Blueprint Epigenome project WGBS and mRNA-seq
WGBS and RNA-seq from 32 venous and cord blood samples were obtained from the Blueprint Epigenome project
(25). Genome coordinates from hg38 were converted to
hg19 using liftOver (24). All other analysis steps were performed identically to the REP data above.
Cancer WGBS and mRNA-seq
Breast invasive carcinoma (BRCA), colon adenocarcinoma
(COAD), rectum adenocarcinoma (READ) and uterine
corpus endometrial carcinoma (UCEC) matched normaltumor WGBS and mRNA-seq samples were obtained from
The Cancer Genome Atlas (TCGA) to train a model of
tumorigenesis. Normal sigmoid colon (E106) WGBS and
mRNA-seq data were obtained from REP (22). HCT116
DKO1 (bi-allelic knockout of DNMT1 and DNMT3b)
WGBS and mRNA-seq data were obtained from Blattler
et al. (26). All other analysis steps were performed identically to the REP data above.
Single window (SW)
We computed the average methylation across a single, fixed
±1 kb window around the TSS of each gene (17,27). We
performed logistic regression to predict differential expression from the average methylation change around the TSS
(Figure 1A and B). Logistic regression cross-validation was
run with 1000 maximum iterations of the optimization algorithm.
Differentially methylated regions (DMRs)
We used DSS-single to compare DMRs between individual
samples (28). We identified DMRs (P < 0.01) and used their
size (bp), average differential methylation, and stranded distance (bp) to the closest TSS (0 if overlapping by ≥1 bp)
as features for gene expression change classification with a
Random Forest (RF) classifier with 1001 estimators (Figure
1A and B).
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value removed from its local context. Recent work, however,
has indicated that a large number of methylation patterns
associate with differential gene expression (16). For example, methylation at CpG island-shores, regions of decreased
CpG density flanking CpG islands, correlate with differential gene expression in colon cancer (17). Further, long
hypomethylated domains in cancer often contain downregulated genes (17). Positive correlations between gene
body methylation and gene expression have also been frequently observed (18,19).
Here, we present a new approach to predict gene expression changes that accounts for all methylation changes
around the TSS. We have previously shown the importance
of capturing methylation changes around the TSS to find
patterns of methylation change that associate with expression changes using an unsupervised approach (16,20,21).
We now build upon these results to develop a supervised
method called ME-Class (Methylation-based Expression
Classification), which classifies differential expression using
signatures of differential methylation.
We use ME-Class to investigate alternate representations
of DNA methylation and CpG density to identify methylation features that are most important in predicting expression change using data from the Roadmap Epigenomics
Project. We then use ME-Class to examine the role methylation associated expression changes play in hematopoiesis
using data from the Blueprint Epigenome project. Lastly,
we demonstrate that ME-Class can identify a set of genes
with cancer-specific expression-associated DNA methylation changes that are silenced in tumor cells, but that are
re-expressed when methylation is removed.
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Regions of interest (ROI)

ME-Class

Figure 1. Models of DNA methylation and validation framework for predicting differential gene expression change from differential DNA methylation. (A) Heat map indicates methylation status at individual CpG
sites––red is fully methylated, blue is fully unmethylated––for an example
gene in two samples (Methyl. 1 and Methyl. 2). Individual points below
indicate differential DNA methylation (Methyl. 2––Methyl. 1) across the
example gene at individual CpG sites. (B) Example regions that would be
used to calculate the single window (SW) and differentially methylated region (DMR) using the data in (A). (C) Regions used to calculate methylation features for the Region of Interest (ROI) representation of the gene
in (A). (D) ME-Class representation of the gene in (A). Each individual
point is the differential methylation value used as a feature in a Random
Forest after interpolation and smoothing. (E) Cross-validation comparison framework. Evaluation is performed sample-wise across the 17 sample
comparisons. In the evaluation comparison, genes are split into 10-folds.
Prior to training, each evaluation gene is removed for all other tissues. Further model details are in Table 1. CGI = CpG island.

Gene signatures were constructed as in VanderKraats et al.
with minor modification (16). This signature allows the
model to incorporate the entire profile of methylation
changes across the gene’s promoter region including any
CGI and CGI-shore regions (Figure 1A and D). In addition, these signatures allow comparison of methylation differences between genes, which have CpGs in different locations. We applied a localized z-score normalization of each
differential methylation value in a 10 kb window surrounding the TSS based upon the distribution of methylation values in a 100 kb surrounding anchor window. We created
methylation signatures using a piecewise cubic hermite interpolating polynomial (PCHIP) to interpolate a curve of
z-score normalized differential methylation values in the
10 kb window around the TSS for each differentially expressed gene. The interpolated curve was then subjected to
Gaussian smoothing with a bandwidth of 50 bp. Since CpG
methylation values are highly autocorrelated (30), interpolation and smoothing of the data decrease the influence of
sequencing error at individual CpGs (16). Similar smoothing approaches have shown a marked improvement in the
ability to determine DMRs (31). To obtain discrete features,
we subsampled our interpolated methylation signature at 20
bp resolution. We then used these features with a RF classifier with 1001 estimators. We initially chose a RF classifier
since it provides a nonparametric model, has a low number
of hyperparameters, generates an internal unbiased estimate
of testing error, identifies feature importance, and typically
performs near-optimally with minimal tuning (32). Logistic
Regression (LR) (max iter = 1001), Gradient Boosted Classification Trees (GBCT) (n estimators = 1001), Gaussian
Naı̈ve Bayes (NB), L2 distance-based k-Nearest Neighbors
(kNN) (k = 21), and Dynamic Time Warping (DTW) kNN
(k = 21) were implemented with default parameters other
than stated modifications. All machine learning methods
were implemented with scikit-learn and mlpy (DTW only)
python packages (33,34).
Whole gene methylation models
We also implemented three alternative representations of
methylation data to incorporate the full profile of methylation changes across the entire gene (Supplementary Figure S2A): Whole Scaled Gene (WSG), Whole Gene (WG),
and Uniform Gene Features (UGF). For each representation, we created 125 bins in the regions 5 kb upstream of the
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The Regions of Interest (ROI) classifier reduces DNA
methylation to multiple averaged values across annotated
gene elements (upstream, exon, intron and downstream
bins) as features for a Random Forest (RF) to predict expression class (Figure 1C). ROI classifier features were implemented as described in (29) to predict differential expression class rather than single sample binned expression values. We used a RF classifier with 100 trees as originally described. Increasing the number of trees to 1001 increased
run time substantially without an appreciable increase in
performance (Supplementary Figure S1).
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Classifier performance
To evaluate the amount of data needed to train ME-Class,
we divided the 17 REP datasets into eight samples that were
held out for evaluation and nine samples that were used for
training. For a given number of training samples (n), nine
random permutations of n pairwise comparisons were chosen from the training samples and used to train nine MEClass classifiers. The resulting nine classifiers were then evaluated on a fixed set of eight comparisons from the holdout
evaluation samples (Supplementary Figure S10).
To evaluate each classifier, we implemented a conservative two-stage cross-validation framework (Figure 1E) to
ensure that the model does not overfit to any given sample
or individual gene. For a given evaluation, we performed
the following procedure: (i) leave-one-out sample pair cross
validation: We divided all differential training samples into
a training set and an evaluation set. This ensured that no
individual sample from the training set appears in the evaluation set; (ii) 10-fold gene cross validation: we randomly
divided the genes from the evaluation sample into 10-folds.
To evaluate each fold, we first removed examples of all genes
in the evaluation fold from all samples in the training set
prior to training. Thus, if gene A is in the evaluation data,
no examples of gene A for any tissue are used for training.
We then trained on the training samples/genes and evaluated the chosen fold of genes in the evaluation samples.
We then repeated this process 10 times for each fold of the
evaluation sample and for each differential sample in the
dataset. This process helped the classifier generalize across
genes and samples by ensuring that each evaluation gene
does not observe either an example of itself or any other
genes from its individual sample.
Average performance based on the accuracy, reject rate,
positive predictive value (PPV), and negative predictive
value (NPV) was reported across all genes treated as a single pool from all samples. Testing accuracy was defined as
the number of genes with correctly predicted expression divided by total genes returned. Receiver Operator Characteristic (ROC) and Precision Recall (PR) curves were averaged to provide a sample-wise level of reporting. RF feature importance was estimated as Gini importance. Unless
otherwise stated, all statistical comparisons were performed

using FDR-corrected paired, pairwise Wilcoxon rank sum
test in R.
Gene ontology analysis
Gene Ontology analysis was performed by analyzing gene
lists with Functional Annotation Clustering with default
parameters from DAVID (37). Blueprint analysis gene lists
were identified by any genes with ≥90% probability of classification in ≥2 differential samples. Colon cancer gene lists
were identified by any down-regulated genes with a ≥90%
probability of classification by ME-Class (see discussion of
reject rate in Results).
RESULTS
ME-Class predicts gene expression change from differential
methylation in tissue samples
Since the goal of most genome-wide methylation studies is
to identify how changes in methylation alter expression, we
examined the ability of methylation to predict differential
expression change. We first sought to understand whether a
methylation signature approach (i.e. modeling the entirety
of methylation changes around a gene’s TSS) could outperform current DMR, single window (SW), and ROI methods in finding genes with associated differential methylation and expression (Figure 1, Table 1). To compare supervised classifiers, we used WGBS DNA methylation and
RNA-seq data from the Roadmap Epigenomics Project for
17 tissue samples (Supplementary Table S1) (22). We implemented a conservative sample-wise and 10-fold gene-wise
cross-validation framework that ensures the genes in the
evaluation step have not been seen in any tissue during training (Figure 1E). Since patterns of differential DNA methylation can be very similar between datasets, this evaluation
framework tests the strength of the DNA methylation representation and the universality of DNA methylation patterns
rather than the ability to simply recall an observed gene’s
methylation signature.
Using this framework, ME-Class outperformed all methods by receiver operator characteristic (ROC) curve analysis (P < 10−3 for ME-Class compared to each of DMR, SW
and ROI, Figure 2A) and precision-recall (PR) analysis (P
< 10−3 for ME-Class compared to each of DMR, SW and
ROI, Supplementary Figure S3C). In addition, ME-Class
performed better than or equal to each of the other methods analyzed for any individual comparison based on ROC
AUC (area under the curve; Figure 2C). Interestingly, there
was a large variability in the classification performance of
the differential samples. While in the case of keratinocyte
comparisons this could likely be explained by poor sequencing coverage (Figure 2E and F), this per-sample performance difference appeared primarily to be due to fundamental differences in the methylation profiles of the expression classes. The ROC AUC was strongly correlated (Figure 2D, R2 = 0.87) with the average methylation difference
between up- and down-regulated genes in the region +0.5
kb to +2.5 kb relative to the TSS (the most important region for classification, Figure 2B). While we cannot rule out
there is some other technical artifact in the data causing this
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TSS and downstream of the TES (Transcription End Site)
(20 bp resolution). These regions/features were then added
to specific features for each representation as follows. The
WSG representation is an emerging representation in the literature to describe methylation changes by linearly scaling
the methylation profile across the entire gene (22,26,35). To
obtain discrete features, we used 500 bins across the gene
(Supplementary Figure S2B). For the WG representation,
we modeled methylation data as a curve (subsampled to 20
bp resolution) across the entire length of the gene (Supplementary Figure S2C). For the UGF approach, we represented each exon with 10 scaled bins and each intron with
30 scaled bins. Multiple exons or introns were not averaged
together (Supplementary Figure S2D). For WSG, we used
a RF classifier. For both WG and UGF, we used curve similarity as defined with DTW (36), and classified expression
changes using kNN (k = 21).

5104 Nucleic Acids Research, 2017, Vol. 45, No. 9

Table 1. DNA methylation features and classification methods for each model in Figure 1
Features

Gene expression change classification method

Single Window (SW)

mCG/CG ±1 kb of TSS

Logistic regression (LR)

Differentially Methylated Regions (DMR)

Distance from TSS to DMR (bp)
DMR width (bp)
Avg. mCG/CG

Random forest (RF)

Regions of Interest (ROI)

Avg. mCG/CG:
Five 400 bp bins 5 of TSS
First Exon
First Intron
Avg. internal exon
Avg. internal intron
Last exon
Last intron
Five 400 bp bins 3 of txEnd

Random forest (RF)

Methylation-based Expression Classification
(ME-Class)

mCG/CG of 500 bins (20 bp) ±5 kb of TSS

Random forest (RF)

Figure 3. ME-Class identifies more genes at higher accuracy with
expression-associated methylation changes in tissue-specific differential
comparisons in the REP dataset. (A) Classifier accuracy versus 1––reject
rate. (B) Accuracy of testing sample at 90% operating probability of classification. (C) Number of genes identified with expression-associated methylation changes at 90% operating probability of classification. Points in (B)
and (C) indicate the performance of individual REP sample comparisons.
** indicates P < 0.005 and *** indicates P < 0.001. All other comparisons
were not significant for ␣ = 0.05.

correlation, it appears that most normal tissue methylationbased expression classification derives from TSS 3 proximal
methylation changes.
ME-Class generates a list of genes with associated differential methylation and expression
Figure 2. ME-Class outperforms standard methods for tissue-specific expression classification. Methods were evaluated using 17 tissue samples
from the REP with the two-stage cross-validation framework in Figure 1E.
(A) ROC analysis from a combination of all 17 samples (ROC AUC: MEClass, 0.76; ROI, 0.71; DMR, 0.63; SW, 0.66). (B) RF feature importance
from ME-Class trained on all 17 differential comparisons from REP. (C)
ROC AUC for each of the 17 samples comparisons. (D) Mean z-score normalized methylation difference of the region [+0.5 kb, +2.5 kb] relative
to the TSS. (E) Average CpG coverage and (F) average fraction of CpGs
within the 10 kb window around the TSS for each REP sample. S1 and
S2 correspond to the first and second sample in the evaluation differential
comparison. L. Ventr. = Left ventricle, Hippo. = Hippocampus, R. Ventr.
= Right ventricle, Esoph. = Esophagus, R. Atrium = Right Atrium, Keratin. = Keratinocyte, Intest. = Intestine.

Transcription can be influenced by multiple factors other
than DNA methylation, such as transcription factors or
chromatin modifications. Thus, the key issue is whether
ME-Class can be used to identify a subset of genes that have
high quality associations between differential methylation
and expression. For this purpose, we introduced a reject rate
into the classifier that allows us to control for external factors other than methylation that indicate gene expression.
The reject rate excluded genes that cannot be reliably predicted (i.e. they likely do not have methylation-associated
expression changes) using a threshold for the probability of
classification output by each classifier. In practical terms,
the reject rate allows one to set a parameter based on the
cross-validation evaluation error that can control the false
positive rate when running ME-Class on unseen samples. In
Figure 3A, we observe that ME-Class outperformed ROI,
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DNA methylation representation
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3 proximal and TSS regions are most predictive of differential expression
We next sought to understand why ME-Class performed
better by examining which features are most important for
classification. We first developed a series of ME-Class classifiers each using signatures from 5 kb windows centered
at varying distances away from the TSS (Figure 4A and B).
Performance peaks for a window centered 2 kb downstream
of the TSS, indicating that the most important features exist
downstream of the TSS. There was no substantial difference
observed in ROC AUC between the entire 10 kb window
compared for the 2 kb downstream centered 5 kb window
(Figure 4B). This agrees with our analysis of RF feature importance, which showed that the most important features

Figure 4. Importance of DNA methylation changes 3 proximal to TSS
for tissue-specific expression classification. Methods were evaluated using
17 REP tissue samples with the two-stage cross-validation framework in
Figure 1E. (A) ROC AUC and (B) 1-reject rate for ME-Class methylation
signatures created from fixed 5 kb windows centered at varying distances
to the TSS. (C) ROC AUC and (D) 1-reject rate for ME-Class methylation
signatures created using increasing window widths centered at the TSS.
Individual points are the performance of individual REP sample comparisons.

for gene expression classification occur downstream +0.5 to
+2.5 kb of the TSS (Figure 2B).
We next evaluated the use of a Most Important (MI) window within the [+0.5 kb, +2.5 kb] region around the TSS
of each gene in the REP dataset (Supplementary Figure
S5). Both a SW classifier trained on only this region, and a
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SW and DMR methods in accuracy and proportion of the
genes returned across all rejection rates.
We next set the classification probability at 90% and examined how many genes were returned by each method and
the accuracy of this list. ME-Class returned significantly
more genes than the SW and ROI methods (ROI: P = 2.9
× 10−3 ; SW: P = 9.2 × 10−4 ) and was significantly more
accurate at 90% probability of classification than the DMR
method (DMR: P = 3.0 × 10−3 ) (Figure 3B and C). MEClass returned the largest average number of genes, 217,
at the highest level of accuracy (93.1%). The ROI and SW
methods achieved lower levels of accuracy and returned
a much lower average number of genes (ROI: 81 genes,
86.9% accuracy; SW: 66 genes, 84.5% accuracy). The DMR
method returned a similar average number of genes, 207, but
at the cost of a much lower level of accuracy (83.3%). This
implies that the nearest isolated DMR is often insufficient
to predict the expression class even when tuning the DMR
parameters to find optimal segmentation parameters.
At 90% probability of classification, ME-Class did not
show any bias towards the positive (up-regulated) or negative (down-regulated) class (Supplementary Figure S3A and
B). ME-Class matched or exceeded the accuracy given the
probability of classification, indicating that this probability
can be used as an estimate of the final classification error
in cross-sample comparisons (Supplementary Figure S3D).
This demonstrates that when running ME-Class on new
samples, the probability of classification can be used as an
estimate of the false discovery rate. Meanwhile, the ROI,
SW and DMR approaches all have a lower accuracy than
the probability of classification at high probabilities indicating that they are likely overfit and do not generalize well
to other datasets.
To understand the difference in why ME-Class was highly
predictive of some genes and not others, we examined metagene plots of the methylation signal at predicted genes subset by the probability of prediction. We observed that the
highest predicted genes have the greatest methylation difference between downregulated and upregulated genes in a
[+0.5 kb, +2.5 kb] region around the TSS of each gene, and
that this signal decays with decreasing probability (Supplementary Figure S4). This dampening of the methylation signal can likely be attributed to either noise from the WGBS
assay or biological noise from cell-type heterogeneity.

5106 Nucleic Acids Research, 2017, Vol. 45, No. 9

Alternative models and features to improve ME-Class
We next sought to determine whether the underlying model
used in ME-Class was sufficient for predicting expression.
We were inspired from our previous unsupervised analysis
(16) to design ME-Class to model the changes in methylation levels around the TSS. However, other features, including CpG density, the density of methylated CpG sites, and
gene body methylation, have been described in the literature to have correlations with expression. Thus, we sought
to understand whether adding these features would improve
classification performance.
CpG density does not improve ME-Class but CpG-poor genes
are more predictive
The density of methylated CpGs has been implied as the
important feature for why CGI methylation affects gene silencing (38,39). We thus compared gene signatures computed from the normalized methylation density (mCG/bp),
CpG density or fractional methylation (mCG/CG) to see
which feature performed best. ROC and PR analysis, as
well as examining the relationship between accuracy and
reject rate, show no substantial increased effect of using
mCG/CG rather than mCG/bp. Unsurprisingly, a model
based on CpG density alone performs nearly equivalent to
random guessing (Supplementary Figure S6a). While the
direct addition of CpG density did not improve performance, we found that ME-Class performed worse on CGIassociated and CpG-rich promoters (Supplementary Figure
S7). This is in agreement with prior findings that there is
a stronger correlation between methylation and expression
for genes which had no CpG island as compared to those
with CpG Islands (40). However, since more genes contain
CGIs, ME-Class identifies a strong association (90% probability of prediction) between differential methylation and
expression for more CGI-associated genes (mean = 135 for
REP samples) than CGI-poor genes (mean = 108). A similar trend is observed for CpG-rich (mean = 170) versus
CpG-poor (mean = 73) promoters. Previously, it has been
hypothesized that CGI-associated and CpG-rich genes tend
to remain unmethylated in normal cell-types irrespective of
their expression levels (41); however, our analysis suggests

that while there are better associations between methylation and expression for non-CGI-associated genes, there are
more CGI-associated genes that show strong associations.
The addition of gene body methylation changes does not improve ME-Class
Since gene body methylation has been shown to be positively correlated with gene expression (18,19,40), we examined if we could improve ME-Class by adding additional gene features that modeled methylation changes in
the gene body. ME-Class performance was not substantially
improved by adding features for averaged gene features similar to that of the ROI method such as the average methylation of internal exons, introns, and region downstream of
the gene (Supplementary Figure S6B). This was unsurprising, since feature importance analysis of the ROI classifier
indicated that the most important features for classification
were the methylation levels of the first exon and first intron,
which substantially overlap the region from the TSS to +5
kb.
We also investigated whether other gene representations
could determine whether methylation information from the
gene body could improve classification performance. Therefore, we implemented three alternative approaches to model
DNA methylation throughout a gene: Whole Scaled Gene
(WSG), Whole Gene (WG), and Uniform Gene Features
(UGF) (Supplementary Figure S2B–D). In the WSG approach, the methylation profile is interpolated across the entire gene and then all genes are rescaled to a uniform length.
This is a common method to visualize genomic trends in
genome-wide methylation data (22,26,35). WG is similar,
but the genes are not scaled after interpolation. Lastly, in
the UGF approach methylation is interpolated then methylation features are extracted using a uniform number of bins
for each exon and intron. All alternative approaches include
regions –5 kb of the TSS and +5 kb of the TES. Using ROC
AUC analysis, the TSS-centric (default ME-Class representation) model outperforms the WG (P = 3.7 × 10−5 ) and
UGF (P = 2.3 × 10−5 ) approaches (Supplementary Figure
S2E–G). Further, the TSS-centric approach identifies more
genes on average (TSS: 178, WSG: 112) at a higher average
level of accuracy (TSS: 93%, WSG: 89%) than the WSG approach.
All combined, these results suggest that models that incorporate gene body methylation, whether through average features or whole gene representations, do not substantially outperform models comprising only information from
around the TSS. Our results demonstrate that features in the
gene body and downstream of the TES are minimally important when using differential methylation to classify expression change. Thus, even though there are correlations
between differential gene body methylation and differential
expression, there is minimal new information in the gene
body relative to the information already found in the ±5 kb
region around the TSS.
Optimizing ME-Class
Before using ME-Class to analyze additional samples, we
examined whether we could tune ME-class for better per-
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ME-Class classifier using only features from this region performed substantially worse than ME-Class given data from
the full [–5 kb, +5 kb] region (Supplementary Figure S5),
underscoring the importance of using all the data around
the TSS to represent DNA methylation.
We then designed a series of ME-Class classifiers to examine how the size of the TSS-centered window affects performance. Increasing the window size beyond 10 kb did not
show substantial improvements in ROC AUC (Figure 4C).
However, after the window size increases greater than 10 kb
there is a decrease in the number of genes returned at 90%
probability of classification (P = 4.5 × 10−3 ) (Figure 4D).
Combined, these results indicate that high-resolution features across a window of at least 5 kb wide and shifted 3
proximal of the TSS is sufficient to capture the complexity
of methylation signal around the promoter required for expression prediction in the REP samples.
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Myeloid/Lymphoid differential methylation comparisons are
most predictive of expression change
We next applied ME-Class to identify methylationassociated expression changes in hematopoiesis. We used
WGBS and mRNA-seq datasets provided by the Blueprint
Epigenome project in cord and venous blood composed of
32 isolated samples from 10 cell types. We retrained MEClass using the entire 17 samples from the REP data above
and then used this model to find methylation-associated
expression changes in 469 hematopoietic lineage-wise
differential comparisons. We found a large variation in
the number of genes identified based on the cell-types
being compared. Comparison of relatively distantly related
lymphoid and myeloid lineages resulted in 54–218 genes
(mean = 88) returned at 90% probability of classification
(Figure 5A and B). Gene ontology analysis suggests that
genes identified in myeloid-lymphoid comparisons are
enriched for genes involved in T-cell activation, leukocyte
differentiation and hematopoiesis. Similar performance
results were found if we characterize the classifier based on
ROC AUC (Figure 5B). This contrasts with a comparison
of closely related myeloid cells such as macrophages,
monocytes and dendritic cells, which identified between 0
and 55 genes when comparing any two cell types (mean =
16 genes; P = 2 × 10−16 ) and demonstrate performance
near random guessing (ROC AUC = 0.55 ± 0.04). Neutrophil samples stood out as particularly poor performers
in all comparisons suggesting that either there are not
methylation-associated expression differences in these cells,
or that methylation profiles in these cells are fundamentally
different from that of other tissues (Supplementary Figure
S11).

Based on ROC analysis there was an inverse relationship between the relatedness of the cells being compared
and the ROC AUC from ME-Class (Figure 5C). Similar results were also obtained using an ME-class model trained a
combination of closely- and distantly-related hematopoietic
cell types (Supplementary Figure S12). While other analyses have examined associations upon myeloid (42) and Bcell differentiation (43), this analysis demonstrates that truly
predictive differences in differential DNA methylation primarily reside between the myeloid and lymphoid lineages,
the two major lineages derived from hematopoietic stem
cells.
ME-Class identifies subsets of genes sensitive to demethylation in colon cancer
We next examined whether ME-Class can accurately identify genes that are hypermethylated and silenced in a model
of colon cancer. For this problem, we first trained a cancerspecific ME-Class model using WGBS and mRNA-seq data
from four different normal-tumor differential comparisons
from The Cancer Genome Atlas (TCGA) (BRCA, COAD,
READ and UCEC). We then used this cancer-specific MEClass model to identify methylation-associated changes in
expression in a colon cancer cell line (HCT116) relative to
normal colon tissue (Figure 6A). We observed that the primary peak of feature importance in our trained model shifts
from the region [+0.5 kb, +2.5 kb] downstream of the TSS
in the REP tissue-specific model to the region [–0.5 kb, +1.5
kb] overlapping the TSS in the TCGA normal-tumor model
(Figure 6B). We found a severe class imbalance; 187 genes
with methylation-associated expression changes were identified as down-regulated, but no genes were predicted as
up-regulated. Functional annotation clustering of gene ontology of the 187 down-regulated, identified genes showed
that these genes are enriched for C2H2 zinc fingers, previously shown to be hypermethylated and silenced in carcinogenesis, and are involved in cell adhesion, whose dysregulation is important for tumorigenesis (44). To understand
whether the tumor-associated hypermethylation was functional, we examined what happened to these genes after removal of methylation by double knockout of DNMT1 and
3b (HCT116 DKO1). Genes with an ME-Class signature
showed a significant upregulation of expression relative to
down-regulated genes not identified by ME-Class (Figure
6C, P = 1 × 10−14 ). Our analysis from this model of colon
cancer demonstrates that ME-Class can identify genes likely
regulated by DNA methylation in human disease and is
consistent with the hypothesis that hypermethylation near
the TSS plays a primary role in modulating gene activity
cancer (41,45,46).
DISCUSSION
One challenge in the field of DNA methylation analysis has
been the difficulty of integrative analysis of genome-wide
DNA methylation and expression data. While methods exist to facilitate this task, they have many parameters that
must be set, often with no clear way to make intelligent
choices for their values. For example, DMR and SW approaches require the user to set several parameters (such
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formance. Using the REP dataset, we compared the performance of the RF, Logistic Regression, Gradient Boosted
Classification Trees (GBCT), Naı̈ve Bayes, and k-NN. We
also compared the RF-based approach to a method using DTW as a curve similarity metric for kNN classification. RF, Logistic Regression and GBCT outperformed the
remaining machine learning methods by both ROC AUC
analysis and examining the relationship between accuracy
and reject rate (Supplementary Figure S8). We also found
that ME-Class performed similarly well as long as smoothing parameters were maintained below 200 bp (Supplementary Figure S9A and B). Interpolation and smoothing serve
to decrease inaccuracy of low coverage methylation calls, as
has been observed in DMR callers (31). Changes in the interpolation method also had no substantial effect on performance (Supplementary Figure S9C). To assess how much
training data ME-Class requires for accurate classification,
we separated the REP dataset into nine differential samples for training held out 8 differential samples for evaluation (see details in Materials and Methods). ME-Class was
consistent within 0.02 ROC AUC of the full training set after using three samples (Supplementary Figure S10A) and
showed minimal increases in obtaining consistent gene sets
as the full training set when using more than five samples
(Supplementary Figure S10B) or 20 000 genes (Supplementary Figure S10C).
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Figure 6. ME-Class identifies genes re-expressed after removal of DNA
methylation in a model of colon cancer. (A) Experimental scheme. We first
built an ME-class model using WGBS data from four tumor-normal pairs
from TCGA. We then used this model to identify genes with expressionassociated methylation changes upon tumorigenesis (HCT116) from normal colon (REP) and evaluate the demethylation effect by genetic manipulation (DKO1: bi-allelic knockout of DNMT1 and DNMT3b in HCT116).
(B) Feature importance for the ME-Class training model built from four
TCGA tumor-normal samples (COAD, BRCA, READ, UCEC). C) Violin plots showing the expression fold change in HCT116 DKO1 cells using
down regulated differentially expressed gene sets identified with (n = 187
genes) and without (n = 5370 genes) identified methylation signatures.

as minimum window size or a minimum number of CpGs)
that can drastically change the list of genes with predicted
methylation changes. Our results from REP analysis show
that these methods cannot be used to accurately predict expression from DNA methylation, likely because they cannot
model the signal complexity necessary to associate methylation and expression change (Figure 2). Incorporating the
complexity of patterns, rather than reducing methylation to
a single or even multiple averaged values, is critical for the
success of ME-Class. Alternative gene representations that
incorporate gene body methylation perform no better than
representations that focus on the region around a gene’s
TSS (Supplementary Figure S6B). Thus, the information
obtained from correlations between gene body methylation
and expression is either too noisy, or it is redundant with
information within ±5 kb of the TSS. In the future, it may
be possible to improve ME-Class by adding features specific
to enhancers, but first we need better computational tools
and experimental data across multiple cell types to connect
regulatory units with specific genes.
In this study, we asked whether we could build models
of DNA methylation that would generalize across different
genes and across samples. For this purpose, we established a
strict evaluation framework to test changes in methylation
to identify these most likely affected genes. Using a training
and evaluation paradigm that consists of both cross-sample
and cross-gene evaluation, we have shown that ME-Class
predictions are not overfit to any given dataset. ME-Class
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Figure 5. ME-Class performance is higher for cell comparisons between distally related cell lineages as opposed to directly related ones. (A) Accuracy versus
1-reject rate and (B) ROC of selected cell-types (ROC AUC: Lymphoid versus Myeloid, 0.72 ± 0.02; Megak. versus other Myeloid, 0.68 ± 0.02; Erythrob.
versus Other Myeloid, 0.68 ± 0.02; CD4+ versus CD8+ T cells, 0.66 ± 0.02; Other Myeloid, 0.55 ± 0.03). (C) ME-Class ROC AUC performance for each
sample-wise comparison of hematopoiesis samples. Vb = venous blood, cb = cord blood, Erythrob. = Erythroblast, Alt Act Macrophage = Alternating
activated Macrophage, Inflam Macrophage = Inflammatory Macrophage, Mat Neutrophil = Mature Neutrophil, Megak. = Megakaryocyte. ROC AUC
error is the standard deviation.
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sion (40), and that decreases in methylation downstream of
the TSS co-occur with increases in active H3K4me3 that
also shift downstream of the TSS (49,50). This difference
in expression-associated methylation changes may explain
why methylation appears to play a role in gene silencing in
cancer, but not in development. In addition, the context dependent nature of these models has a profound effect on
downstream applications indicating that different methylation models may need to be trained for different contexts
(i.e. cancer-specific models need to be trained to understand
expression-associated methylation changes in cancer). Once
these models are trained, they are applicable across other
similar datasets.
As more large-scale, genome-wide DNA methylation
studies of the differences between matched normal and tumor samples become available, tools such as ME-class will
prove invaluable to understand how specific methylation
changes affect transcription. In addition, our results show
that ME-Class is a powerful tool to identify genes that are
silenced by methylation in disease and could be used to facilitate the identification of patients who may benefit from
clinically-approved demethylating therapeutics (51).
AVAILABILITY
ME-Class is publicly available on Github at http://github.
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